All In Biotech

Drug Trial Radar · NCT00217737

Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer

A Randomized Phase III Study Comparing 5-FU, Leucovorin and Oxaliplatin Versus 5-FU, Leucovorin, Oxaliplatin and Bevacizumab in Patients With Stage II Colon Cancer at High Risk for Recurrence to Determine Prospectively the Prognostic Value of Molecular Markers

Last checked: Nov 19, 2026Latest source record: Aug 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 2,431 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,431

Actual

Start

Sep 6, 2005

Primary completion

Feb 22, 2024

Study completion May 26, 2026

Sponsor

Sponsor type
NIH
First posted
Sep 22, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This randomized phase III trial studies oxaliplatin, leucovorin, fluorouracil, and bevacizumab to see how well they work compared to oxaliplatin, leucovorin, and fluorouracil in treating patients who have undergone surgery for stage II colon cancer. Drugs used in chemotherapy, such as oxaliplatin, leucovorin, and fluorouracil, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Monoclonal antibodies, such as bevacizumab, may interfere with the ability of tumor cells to grow and spread. It is not yet known whether giving combination chemotherapy together with bevacizumab is more effective than combination chemotherapy alone in treating colon cancer.

Conditions

  • Colon Adenocarcinoma
  • Stage IIA Colon Cancer AJCC v7
  • Stage IIB Colon Cancer AJCC v7
  • Stage IIC Colon Cancer AJCC v7

Interventions

  • BevacizumabBiological

    Given IV

  • FluorouracilDrug

    Given IV

  • LeucovorinDrug

    Given IV

  • OxaliplatinDrug

    Given IV

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Disease-free Survival Rate at 5 YearsTime frame: Assessed every 3 months for patients within 2 years of step 2 randomization, every 6 months during 3-5 years from step 2 randomization, and then every 12 months until 10 years from step 2 randomization

Locations

928 sites in 5 countries. Site status is shown where the registry gives one.

  • Northeast Alabama Regional Medical Center

    Anniston, Alabama

  • University of Alabama at Birmingham Cancer Center

    Birmingham, Alabama

  • Clearview Cancer Institute

    Huntsville, Alabama

  • Mobile Infirmary Medical Center

    Mobile, Alabama

  • Providence Hospital

    Mobile, Alabama

  • Providence Alaska Medical Center

    Anchorage, Alaska

  • Mayo Clinic in Arizona

    Scottsdale, Arizona

  • Banner University Medical Center - Tucson

    Tucson, Arizona

  • Mercy Hospital Fort Smith

    Fort Smith, Arkansas

  • NEA Baptist Memorial Hospital

    Jonesboro, Arkansas

  • Alta Bates Summit Medical Center-Herrick Campus

    Berkeley, California

  • Providence Saint Joseph Medical Center/Disney Family Cancer Center

    Burbank, California

  • Mills-Peninsula Medical Center

    Burlingame, California

  • East Bay Radiation Oncology Center

    Castro Valley, California

  • Eden Hospital Medical Center

    Castro Valley, California

  • Valley Medical Oncology Consultants-Castro Valley

    Castro Valley, California

  • John Muir Medical Center-Concord

    Concord, California

  • City of Hope Comprehensive Cancer Center

    Duarte, California

  • Bay Area Breast Surgeons Inc

    Emeryville, California

  • Valley Medical Oncology Consultants-Fremont

    Fremont, California

  • Washington Health

    Fremont, California

  • Saint Jude Medical Center

    Fullerton, California

  • Glendale Memorial Hospital and Health Center

    Glendale, California

  • Marin Cancer Care Inc

    Greenbrae, California

  • Marin General Hospital

    Greenbrae, California

  • Saint Rose Hospital

    Hayward, California

  • Loma Linda University Medical Center

    Loma Linda, California

  • Veterans Affairs Loma Linda Healthcare System

    Loma Linda, California

  • USC / Norris Comprehensive Cancer Center

    Los Angeles, California

  • Contra Costa Regional Medical Center

    Martinez, California

  • Fremont - Rideout Cancer Center

    Marysville, California

  • Providence Holy Cross Medical Center

    Mission Hills, California

  • Memorial Medical Center

    Modesto, California

  • El Camino Hospital

    Mountain View, California

  • Palo Alto Medical Foundation-Camino Division

    Mountain View, California

  • Sutter Cancer Research Consortium

    Novato, California

  • Wilma Chan Highland Hospital

    Oakland, California

  • Alta Bates Summit Medical Center - Summit Campus

    Oakland, California

  • Bay Area Tumor Institute

    Oakland, California

  • Hematology and Oncology Associates-Oakland

    Oakland, California

Showing 40 of 928 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.